卒中患者取栓术后不明原因早期神经功能恶化的发生率、相关因素与机制
本研究为 ESCAPE-NA1 试验的事后分析,纳入 1063 例前循环大血管闭塞并接受血管内取栓的缺血性卒中患者。结果显示,不明原因早期神经功能恶化(unEND)总体发生率为 11.0%,与麻醉使用、年龄增长及发病至再灌注时间延长独立相关;在 CT 灌注亚组中,梗死超出缺血半暗带(IEBP)与 unEND 强相关。
要点
- 取栓术后早期神经功能恶化中约 68% 为不明原因,总体发生率为 11.0%。
- 麻醉使用、年龄每增 1 岁及发病至再灌注每延长 10 分钟与 unEND 独立相关。
- 梗死体积超出初始低灌注组织 ≥10 mL 者发生 unEND 的风险约为 7 倍。
核心结论
- unEND 见于约 10% 的大血管闭塞取栓患者,与高龄、发病至再灌注时间延长及麻醉使用相关。
- 发生梗死超出缺血半暗带(IEBP)的患者出现 unEND 的可能性约为 7 倍。
研究设计与样本
- ESCAPE-NA1 试验的事后分析,该试验为双盲、多中心、随机对照试验,比较 nerinetide 与安慰剂。
- 纳入 1063 例接受血管内取栓的前循环大血管闭塞成人缺血性卒中患者,中位年龄 70.8 岁,女性 526 例(49.5%)。
主要发现
- 172 例(16.2%)发生 END,其中 117 例(68.0%)为 unEND,总体 unEND 发生率为 11.0%。
- END 相关事件分布:血栓/血栓栓塞事件 20 例(11.6%),出血事件 27 例(15.7%),两者兼有 8 例(4.7%)。
- 与 unEND 独立相关的变量:麻醉使用 aOR 7.23(95%CI 4.63-11.30),年龄每增 1 岁 aOR 1.02(95%CI 1.01-1.04),发病至再灌注每延长 10 分钟 aOR 1.02(95%CI 1.01-1.03)。
- 在基线 CTP 可用的 410 例中,unEND 与 IEBP 相关(OR 6.81,95%CI 2.58-18.01),IEBP 体积每增 10 mL 的 OR 为 1.07(95%CI 1.01-1.13)。
关键数值与推荐
- END 定义为基线或取栓后 2-6 小时(取较低值)至 24 小时评估时 NIHSS 评分增加 ≥4 分。
- unEND 定义为不伴出血或血栓/血栓栓塞事件的 END。
- IEBP 定义为随访梗死体积较初始临界低灌注组织体积(Tmax >6 秒体积)大至少 10 mL。
临床怎么用
- 取栓术后发生不明原因神经功能恶化时,应关注麻醉方式、发病至再灌注时间及高龄等可调控或预警因素。
- 术后 CT 灌注提示梗死超出初始低灌注区(IEBP)可能有助于识别 unEND 高风险患者。
局限性
- 本研究为 ESCAPE-NA1 试验的事后分析,结果可能受原试验入组标准影响。
- CTP 亚组分析仅纳入 410 例,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Early neurologic deterioration (END) in ischemic stroke after endovascular thrombectomy (EVT) is a frequent complication that remains unexplained in most cases. We aimed to explore the incidence of, and associated variables with, unexplained END (unEND). METHODS: This is a post hoc analysis of the ESCAPE-NA1 trial, a double-blind, multicentric, randomized clinical trial evaluating nerinetide vs placebo in adult ischemic stroke patients with anterior circulation large vessel occlusion treated with EVT. END was defined as an increase of ≥4 points in the NIH Stroke Scale score between baseline or 2-6 hours after EVT (whichever was the lowest) and 24-hour assessment. The primary outcome was unEND, defined as END without associated hemorrhagic or thrombotic/thromboembolic events. Backward stepwise multivariable logistic regression was used to identify baseline variables independently associated with unEND. In the CT perfusion (CTP) subgroup, regression analysis adjusted for baseline covariates was used to assess the association between unEND and infarct extension beyond the penumbra (IEBP), defined as a follow-up infarct volume larger by at least 10 mL than the initial critically hypoperfused tissue volume (time-to-maximum >6-second volume). RESULTS: Overall, 1063 patients were included in this study; the median age was 70.8 years (interquartile range 60.7-79.7), and 526 (49.5%) were women. Among them, 172 (16.2%) experienced END: 20 (11.6%) had an associated thrombotic/thromboembolic event, 27 (15.7%) had an associated hemorrhagic event, 8 (4.7%) had both associated thrombotic/thromboembolic and hemorrhagic events, and 117 (68.0%) had an unEND (overall incidence of unEND = 11.0%). Variables independently associated with unEND were anesthesia use (adjusted odds ratio [aOR] 7.23, 95% CI 4.63-11.30), age (aOR 1.02, 95% CI 1.01-1.04 per 1-year increase), and onset-to-reperfusion time (aOR 1.02, 95% CI 1.01-1.03 per 10-minute increase). In patients with available baseline CTP (n = 410), unEND was associated with the presence of IEBP (OR 6.81, 95% CI 2.58-18.01) and larger IEBP volume (OR 1.07, 95% CI 1.01-1.13 per 10-mL increase). DISCUSSION: UnEND occurred in approximately 10% of large vessel occlusion thrombectomy patients and was associated with older age, longer onset-to-reperfusion time, and anesthesia use. Patients who experienced IEBP, that is, 24-hour infarct volume extension beyond the initial hypoperfused tissue, were 7 times more likely to develop unEND.
引用
- Pensato U, Coutts SB, van Adel B, et al. Incidence, Associations, and Mechanisms of Unexplained Early Neurologic Deterioration After Thrombectomy in Stroke Patients. Neurology. 2025. PMID: 40737569. doi:10.1212/WNL.0000000000213945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。